{"adverse_reactions":["6 ADVERSE REACTIONS"],"clinical_pharmacology":["12 CLINICAL PHARMACOLOGY"],"clinical_studies":["14 CLINICAL STUDIES"],"contraindications":["4 CONTRAINDICATIONS"],"description":["11 DESCRIPTION"],"dosage_and_administration":["2 DOSAGE AND ADMINISTRATION"],"dosage_forms_and_strengths":["3 DOSAGE FORMS AND STRENGTHS"],"drug_abuse_and_dependence":["9 DRUG ABUSE AND DEPENDENCE"],"drug_interactions":["7 DRUG INTERACTIONS"],"effective_time":"20160404","id":"2fab077c-d3f4-5f8f-e054-00144ff8d46c","indications_and_usage":["1 INDICATIONS AND USAGE"],"information_for_patients":["17 PATIENT COUNSELING INFORMATION"],"nonclinical_toxicology":["13 NONCLINICAL TOXICOLOGY"],"openfda":{},"overdosage":["10 OVERDOSAGE"],"package_label_principal_display_panel":["18 PACKAGE LABEL.PRINCIPAL DISPLAY PANEL GABAPENTIN 300mg30CAPS"],"set_id":"2fab077c-d3f3-5f8f-e054-00144ff8d46c","spl_product_data_elements":["GABAPENTIN GABAPENTIN FERROSOFERRIC OXIDE SHELLAC STARCH, CORN D&C YELLOW NO. 10 FD&C BLUE NO. 1 FD&C BLUE NO. 2 FD&C RED NO. 40 GELATIN MANNITOL SODIUM LAURYL SULFATE TALC FERRIC OXIDE YELLOW GABAPENTIN GABAPENTIN PROPYLENE GLYCOL FERRIC OXIDE RED SILICON DIOXIDE TITANIUM DIOXIDE 2666"],"storage_and_handling":["15 STORAGE AND HANDLING"],"use_in_specific_populations":["8 USE IN SPECIFIC POPULATIONS"],"version":"1","warnings_and_cautions":["​5 WARNINGS AND PRECAUTIONS"]}